Carcinoma, Hepatocellular: all 3,251 studies
Page 21 of 33. Open to participants first (976), then studies with results posted, then the rest; newest registration first within each.
- Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCCCompletedNCT04212286Not applicable
- Diagnostic Efficacies of Sonazoid-CEUS and EOB-MRI in Patients With High Risk of HCCStatus unknownNCT04212273Not applicable
- Interest of the Intervention of a Nurse Coordinator in Complex Care PathwayStatus unknownNCT04209491
- Combined Radiotherapy and Radiofrequency Ablation for Hepatocellular CarcinomaStatus unknownNCT04202523Phase 3
- RT+ Anti-PD-1 for Patients With Advanced HCC (RT+PD-1-HCC)Status unknownNCT04193696Phase 2
- Sleep Apnoea Syndrome and Hepatocellular CarcinomaWithdrawnNCT04190498
- Discrepancies in Management of Hepatocellualr Carcinoma Between Practice and RecommendationsStatus unknownNCT04189809
- Regorafenib Plus Tislelizumab as First-line Systemic Therapy for Patients With Advanced Hepatocellular CarcinomaStatus unknownNCT04183088Phase 2
- Neo-TACE-HAIC for PVTT-HCCStatus unknownNCT04181931Not applicable
- Atezolizumab Plus Bevacizumab With HCC and HBV InfectionActive, not recruitingNCT04180072Not applicable
- The Impact on Hepatic Recurrence After Adjuvant Chemotherapy With Intraarterial Infusion of Idarubicin-LipiodolWithdrawnNCT04178642Phase 2
- Hypermethylation of VTRNA2-1 Promoter in HCC OutcomeCompletedNCT04177316
- Anti-PD-1 Antibody Plus DEB-TACE for BCLC Stage A/B HCCStatus unknownNCT04174781Phase 2
- A Study of the Combination of Anti-PD-1 AK105 and Anlotinib in First-line Hepatocellular Carcinoma (HCC)CompletedNCT04172571Phase 2
- Endoarterial Treatment in Combination With Percutaneous Thermoablation for Medium-sized and Oligonodular Hepatocellular CarcinomasCompletedNCT04172194
- Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING)CompletedNCT04170556Phase 1/2
- Systemic Chemotherapy Plus Lenvatinib and Toripalimab for HCC With Extrahepatic MetastasisStatus unknownNCT04170179Phase 2
- Toripalimab Plus Stereotactic Body Radiotherapy for HCC With PVTTStatus unknownNCT04169399Phase 2
- Lenvatinib Following Liver Transplantation in Patients With High-Risk Hepatocellular CarcinomaStatus unknownNCT04168944Phase 2/3
- Combination of Sintilimab and Stereotactic Body Radiotherapy in Hepatocellular Carcinoma (ISBRT01)Status unknownNCT04167293Phase 2/3
- Changing Trends in HCC ProceduresStatus unknownNCT04163627
- Safety and Efficacy of Allogeneic NK Cells Therapy in Patients With Advanced Hepatocellular CarcinomaStatus unknownNCT04162158Phase 1/2
- A Study to Assess Overall Survival and Treatment Patterns for Advanced Liver Cancer Participants Who Received Nivolumab TherapyCompletedNCT04161911
- Comparison of Efficacy in SBRT of HCC ≤5 cm With or Without TACEStatus unknownNCT04161287
- Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated CirrhosisStatus unknownNCT04160897
- Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid TumorsCompletedNCT04157985Phase 3
- Anlotinib In Combination With RFA And TACE in Patients With Middle-advanced HCCStatus unknownNCT04157140Phase 2
- Combined Immunotherapy and Targeted Therapy for Hepatocellular CarcinomaStatus unknownNCT04152356
- Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAETerminatedNCT04150874Early Phase 1
- National Translational Science Network of Precision-based Immunotherapy for Primary Liver CancerCompletedNCT04145141
- Sorafenib Plus TACE Versus Sorafenib Alone as Postoperative Adjuvant Treatment for Resectable Primary Advanced HCCStatus unknownNCT04143191Phase 3
- Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTTStatus unknownNCT04127396Phase 4
- Safety and Efficacy Study of Radioembolization in Combination With Durvalumab in Locally Advanced and Unresectable HCCCompletedNCT04124991Phase 1/2
- Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC)Active, not recruitingNCT04123379Phase 2
- GPC3-targeted CAR-T Cell for Treating GPC3 Positive Advanced HCCStatus unknownNCT04121273Phase 1
- Phase II Study of PRL3-ZUMAB in Advanced Solid TumorsCompletedNCT04118114Phase 2
- Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid TumorsTerminatedNCT04116320Phase 1
- Liquid Biopsy in Hepatocellular CarcinomaStatus unknownNCT04111029
- Safety and Efficacy of Radiotherapy Plus Sintilimab for HCC With Portal Vein Tumor ThrombosisStatus unknownNCT04104074Phase 1
- TACE Plus Sorafenib Versus TACE Alone for Recurrent Intermediate Hepatocellular CarcinomaCompletedNCT04103398Phase 3
- To Explore the Diversity of Intestinal Flora in Patients With Advanced HCC Combin ed With Anti-PD-1 and Targeted Drug Therapy and the Correlation Between Metabolites and Therapeutic EffectStatus unknownNCT04101747
- T Cells co- Expressing a Second Generation Glypican 3-specific Chimeric Antigen Receptor With Cytokines Interleukin-21 and 15 as Immunotherapy for Patients With Liver Cancer (TEGAR)WithdrawnNCT04093648Phase 1
- Indocyanine Green (ICG) Guided Tumor ResectionCompletedNCT04084067Phase 1
- Study of Anlotinib After Lenvatinib in Patients With Hepatocellular CarcinomaStatus unknownNCT04080154Phase 2
- Surgical Stages of Liver Cirrhosis In Patients With Hepatocellular CarcinomaStatus unknownNCT04076631
- Safety and Efficacy Study of Sintilimab Combined With IBI305 in Patients With Advanced Hepatocellular CarcinomaCompletedNCT04072679Phase 1
- Sorafenib Plus Toripalimab for Unresectable HCC With Portal Vein Tumor ThrombusStatus unknownNCT04069949Phase 1/2
- Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC)CompletedNCT04069468
- Study of Oligo-Fucoidan in Advanced Hepatocellular Carcinoma (HCC)TerminatedNCT04066660Not applicable
- TACE Combined With Anlotinib Treatment of Middle-advanced Hepatocellular Carcinoma (HCC) PatientsStatus unknownNCT04066543Phase 2
- The Efficacy of Transarterial Chemoinfusion (TAI) Combine Lenvatinib in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT04053985Phase 3
- The Impact on Recurrence Risk of Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.Status unknownNCT04053972Phase 3
- Anlotinib Hydrochloride Combined With Sintilimab Injection in the Treatment of Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT04052152Phase 2
- Effectiveness of Drug Eluting TACE in Primary HCCStatus unknownNCT04048317Early Phase 1
- RFA Versus SBRT for Recurrent Small HCCCompletedNCT04047173Phase 3
- Lenvatinib Plus Nivolumab Versus Lenvatinib for Advanced Hepatocellular Carcinoma With Hepatitis B Virus InfectionWithdrawnNCT04044651Phase 2/3
- HAIC Plus Lenvatinib and Toripalimab for Advanced HCCCompletedNCT04044313Phase 2
- Sintilimab Combined With Lenvatinib in Local Advanced Hepatocellular CarcinomaStatus unknownNCT04042805Phase 2
- A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular CarcinomaCompletedNCT04039607Phase 3
- Combination Camrelizumab (SHR-1210) and Apatinib for Downstaging/Bridging of HCC Before Liver TransplantStatus unknownNCT04035876Phase 1/2
- Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT CellsStatus unknownNCT04032392Phase 1
- Low-contrast Dose Liver CT Using Lean Body Weight Low Monoenergetic Images and Deep Learning-based ReconstructionCompletedNCT04027556Not applicable
- Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) OralWithdrawnNCT04025567Phase 2
- Neoadjuvant Radiotherapy for HCC Involving Type I PVTTStatus unknownNCT04025437Phase 2/3
- An Investigational Scan (Magnetic Resonance Elastography) in Detecting Treatment Response in Patients With Advanced Liver CancerCompletedNCT04022746Not applicable
- Observational Study on Patients With Hepatocellular Carcinoma (HCC)Status unknownNCT04021056
- SNMC (Stronger Neo-Minophagen C ) for Acute Hepatitis Post Transarterial Chemoembolization TherapyCompletedNCT04015245Phase 4
- SHR-1210 Plus Apatinib in Patients With Advanced-Stage Hepatocellular CarcinomaStatus unknownNCT04014101Phase 2
- EXplanted LIver and Ex-vivo Pancreatic Specimen Evaluation by 7 TESLA MRIStatus unknownNCT04012021Not applicable
- A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid TumorActive, not recruitingNCT04008797Phase 1/2
- A Study of Overall Survival in Participants With Unresectable Hepatocellular CarcinomaCompletedNCT04008082
- Comparing SonoVue With Sonazoid Using CEUS-LIRADS in HCCStatus unknownNCT04006275Phase 3
- YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)CompletedNCT04000737Phase 2
- Study of ET140202 T Cells in Adults With Advanced Hepatocellular CarcinomaTerminatedNCT03998033Phase 1
- TACE Combined With Methylcantharidimide Tablets in the Treatment of Large and Unresectable Hepatocellular CarcinomaStatus unknownNCT03996681Phase 4
- A Study of CD147-targeted CAR-T by Hepatic Artery Infusions for Very Advanced Hepatocellular CarcinomaStatus unknownNCT03993743Phase 1
- Postoperative Antimicrobial Prophylaxis Versus Placebo for Infection Prevention in HCC After Liver ResectionSuspendedNCT03990974Phase 3
- Radiofrequency Ablation Plus Radiotherapy for Small Hepatocellular CarcinomaStatus unknownNCT03988998Phase 3
- Multi-center Clinical Application of Hangzhou Criteria in Liver Transplantation for Hepatocellular CarcinomaStatus unknownNCT03985644
- Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.Active, not recruitingNCT03983954Phase 1
- 68 Ga PSMA PET/MRI for Hepatocellular CarcinomaCompletedNCT03982407Early Phase 1
- Radiomics-based Non-invasive Classifier Research for HCC-related Liver TransplantationStatus unknownNCT03981848
- 4th Generation Chimeric Antigen Receptor T Cells Targeting Glypican-3CompletedNCT03980288Phase 1
- EXALT: EXercise Attenuates Liver Tumors TrialTerminatedNCT03979547Not applicable
- Albumin for Hepatocellular CarcinomaStatus unknownNCT03974074Phase 3
- A Clinical Study Evaluating the Use of HLX10 in Combination With HLX04 for the Treatment of Advanced Hepatocellular Carcinoma (HCC) PatientsStatus unknownNCT03973112Phase 2
- AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular CarcinomaStatus unknownNCT03971747Phase 1
- A Randomized Phase II Trial of Surgery Plus Sorafenib vs. Sorafenib Alone for Hepatocellular Cancer (HCC) With Portal Vein InvasionStatus unknownNCT03971201Phase 2
- A Study of Tivozanib in Combination With Durvalumab in Subjects With Advanced Hepatocellular CarcinomaTerminatedNCT03970616Phase 1/2
- Drug-eluting Bead Transarterial Chemoembolisation (DEB-TACE) Versus (VS) Conventional Transarterial Chemoembolisation (cTACE) for Unresectable Hepatocellualr Carcinoma (HCC)Status unknownNCT03969576Not applicable
- Safety and Efficacy of PD-1 Inhibitors in Patients With Liver TransplantStatus unknownNCT03966209Phase 1
- Cabozantinib toLERANCE Study in HepatoCellular Carcinoma (CLERANCE)CompletedNCT03963206Phase 4
- Fingerprint Characterization Tyrosine Kinase Inhibitors in Advanced HCCTerminatedNCT03958669
- Analysis of cfDNA in Patients With Hepatocarcinoma and Treated by Sorafenib or RegorafenibTerminatedNCT03956940Not applicable
- SBRT as Bridging Therapy for Hepatocellular Carcinoma Patients on Transplant WaitlistStatus unknownNCT03950102Not applicable
- A Multicenter Study of Anlotinib in Hepatocellular Carcinoma (HCC) Patients at High Risk of Post Surgery RecurrenceTerminatedNCT03945799Phase 1/2
- Anti-PD-1therapy Combined With Thermal Ablation for Advanced HCCCompletedNCT03939975Phase 2
- A Prospective, Randomized, Multicenter Study of Comparison of TACE Combination With and Without EBRT for Hepatocellular Carcinoma With Portal Vein Tumor ThrombiStatus unknownNCT03939845Phase 3
- Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract CarcinomaActive, not recruitingNCT03937830Phase 2
- Phase II of Lenvatinib Plus Toripalimab for Advanced HCCWithdrawnNCT03919383Phase 2